Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
Some Inconvenient Facts About Yervoy, Bristol-Myers' New "Holy Grail" Cancer Drug
More from Markets - CBS News
Posted on March 28, 2011 at 12:32 PM EDT
BMS paid $2.1 billion to acquire a drug that may have cost less than $400 million to develop.
Read More >>
Bemis Co., Inc.
Ryder System, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here